Toggle Offcanvas
...
Global Government Tenders

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Successive Delivery Of Medicinal And Complementary Products (Cyclosporin, Methotrexat, Takrolimus, Folic Acid, Momenazone, Emollients) For The Implementation Of Non -Commercial Clinical Trial "Prospective, Randomized, Open Clinical Examination Of The 3Rd Phase With Blindness Of The End Point Assessment Assessing The Effectiveness And Safety Of The Use Of Cyclosporine Atopic

Uniwersytet Medyczny w Łodzi Poland has Released a tender for Successive Delivery Of Medicinal And Complementary Products (Cyclosporin, Methotrexat, Takrolimus, Folic Acid, Momenazone, Emollients) For The Implementation Of Non -Commercial Clinical Trial "Prospective, Randomized, Open Clinical Examination Of The 3Rd Phase With Blindness Of The End Point Assessment Assessing The Effectiveness And Safety Of The Use Of Cyclosporine Atopic in Pharmaceuticals. The tender was released on Mar 29, 2025.

Country - Poland

Summary - Successive Delivery Of Medicinal And Complementary Products (Cyclosporin, Methotrexat, Takrolimus, Folic Acid, Momenazone, Emollients) For The Implementation Of Non -Commercial Clinical Trial "Prospective, Randomized, Open Clinical Examination Of The 3Rd Phase With Blindness Of The End Point Assessment Assessing The Effectiveness And Safety Of The Use Of Cyclosporine Atopic

Deadline - Apr 28, 2025

GT reference number - 105979435

Product classification - Pharmaceutical products

Organization Details:

  Address - Poland

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 105979435

  Document Type - Tender Notices

Notice Details and Documents:

Description - Description: Successive delivery of medicinal and complementary products (cyclosporin, methotrexat, takrolimus, folic acid, momenazone, emollients) for the implementation of non -commercial clinical trial "prospective, randomized, open clinical exami nation of the 3rd phase with blindness of the end point assessment assessing the effectiveness and safety of the use of cyclosporine atopicClinical examination "Prospective, randomized, open clinical examination of the 3rd phase with blindness of the ending point assessment assessing the effectiveness and safety of the use of cyclosporin and methotrexate in children and adolescents with atopic dermatitis with moderate to severe intensity" as part

Gt Ref Id - 105979435

Deadline - Apr 28, 2025

Share share

Similar Tenders :

Create Account

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database